Nobilis Therapeutics Inc.
Nobilis Therapeutics, Inc.
- UEI
- GDY7VD6EX3L4
- CAGE
- 7XUF9
- Primary NAICS
- Not on record
- SAM.gov registration
- Expired
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Website
- nobilistx.com
- Founded
- 2016
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Portable hand-held proprietary xenon inhaler for rapid reduction of opioid withdrawal symptoms - summary/abstract people… | National Institute on Drug Abuse | $959,976 |
Quick answers
What is Nobilis Therapeutics Inc.'s UEI?
Nobilis Therapeutics Inc.'s Unique Entity ID (UEI) in SAM.gov is GDY7VD6EX3L4.
What is Nobilis Therapeutics Inc.'s CAGE code?
Nobilis Therapeutics Inc.'s CAGE code is 7XUF9.
Is Nobilis Therapeutics Inc. registered in SAM.gov?
Nobilis Therapeutics Inc.'s SAM.gov registration expired on April 1, 2025.
What is Nobilis Therapeutics Inc.'s most recent federal award?
Nobilis Therapeutics Inc.'s most recent federal grant award is Portable hand-held proprietary xenon inhaler for rapid reduction of opioid withdrawal symptoms - summary/abstract people… (R41DA055403), from National Institute on Drug Abuse, on September 30, 2021.
On GovTribe
See Nobilis Therapeutics Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors